Patients should never be charged for Paxlovid (nirmatrelvir/ritonovir) or Lagevrio (molnupiravir). If you or another patient was told you would be charged for these medications, please report this to CDPH to help address this issue.
While there is currently no cost for most COVID-19 treatments themselves, the treating facility may charge for the administration of the drug. Medicare and Medicaid cover all costs. Check your insurance plan, as many large private insurance plans cover costs. If you do not have insurance, ask the treatment facility if there are fees.
As of March 22, 2022 the Health Resource & Services Administration (HRSA) program has stopped accepting claims for COVID-19 testing and treatment due to lack of sufficient funds. Click here for more information.
Through the California Department of Health Care Services, the COVID-19 Uninsured Group program is a new COVID-19 program that replaces Presumptive Eligibility (PE) for COVID-19. The COVID-19 Uninsured Group program provides temporary, no cost diagnostic testing, testing-related services, and treatment services, including all medically necessary care, which includes associated office, clinic, or emergency room visits related to COVID19. This program is available to uninsured and underinsured individuals determined eligible by a Qualified Provider (QP) based on preliminary applicant information. Click here for more information.